Skin grafts based on CRISPR-edited iPS cells to treat epidermolysis bullosa
December 19, 2019 10:03 PM UTC
INDICATION: Blistering disorder...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Blistering disorder...
BCIQ Company Profiles
BCIQ Target Profiles